Bhatia Sangeeta N. — SEC insider filings
SEC reporting owner CIK 1643921. 21 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2020-10-07 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 46 legs across 19 filings — 20,815 shares, $6,494,423 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 2,670 shares @ $267.92 ($715,346) in VERTEX PHARMACEUTICALS INC / MA, filed 2020-10-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | 21 | — | 46 legs · 20,815 sh · $6,494,423 | 14 |
Insider filings — Bhatia Sangeeta N.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 271 @ $547.86 | EDGAR |
| 2026-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 943 @ $0 · Sale (S): 318 @ $423.73 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 266 @ $500 | EDGAR |
| 2025-08-29 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 266 @ $386.69 | EDGAR |
| 2025-05-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 796 @ $0 · Sale (S): 400 @ $505.86 | EDGAR |
| 2024-09-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 646 @ $152.74 · Sale (S): 646 @ $500 · Option exercise (M): 646 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 1,292 @ $152.74 · Sale (S): 1,292 @ $466.29 · Option exercise (M): 1,292 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 1,001 @ $0 · Sale (S): 467 @ $402.95 | EDGAR |
| 2023-10-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 243 @ $375 | EDGAR |
| 2023-10-11 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 242 @ $360 | EDGAR |
| 2023-08-11 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 242 @ $345.51 | EDGAR |
| 2023-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 1,168 @ $0 · Sale (S): 62 @ $345.93 · Sale (S): 172 @ $346.69 · Sale (S): 120 @ $348.16 · Sale (S): 163 @ $349.82 · Sale (S): 63 @ $351.20 | EDGAR |
| 2022-10-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 621 @ $310 | EDGAR |
| 2022-08-10 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 45 @ $290.18 · Sale (S): 164 @ $291.76 · Sale (S): 204 @ $293.15 · Sale (S): 161 @ $294.24 · Sale (S): 47 @ $295.53 | EDGAR |
| 2022-08-02 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 99 @ $276.65 · Sale (S): 200 @ $277.95 · Sale (S): 160 @ $279.28 · Sale (S): 99 @ $280.22 · Sale (S): 58 @ $281.03 · Sale (S): 5 @ $282.34 | EDGAR |
| 2022-05-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 40 @ $255.40 · Sale (S): 280 @ $257.51 · Sale (S): 120 @ $258.90 · Sale (S): 120 @ $259.75 · Sale (S): 80 @ $260.82 · Sale (S): 91 @ $261.91 · +1 more | EDGAR |
| 2022-05-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 1,449 @ $0 | EDGAR |
| 2022-04-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 1,907 @ $125.71 · Sale (S): 1,907 @ $280.20 · Option exercise (M): 1,907 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 285 @ $208.96 · Sale (S): 153 @ $210.01 · Sale (S): 121 @ $211 | EDGAR |
| 2021-05-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 1,842 @ $0 | EDGAR |
| 2020-10-07 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 8,729 @ $126.68 · Sale (S): 291 @ $262.66 · Sale (S): 594 @ $263.54 · Sale (S): 892 @ $264.60 · Sale (S): 1,787 @ $265.82 · Sale (S): 2,070 @ $266.66 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643921 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs